Generic Name: Empagliflozin
Brand Name: Jardiance
Manufacturer: Boehringer Ingelheim (Canada) Ltd.
Indications: Diabetes mellitus, type 2 with high cardiovascular risk
Project Status: Complete
Date Recommendation Issued: October 26, 2016
Recommendation Type: Reimburse with clinical criteria and/or conditions